In human colon cancer, CD26 was identified as a novel marker for cancer stem cells, and injection of CD26+ cells into SCID mice resulted in the development of distant metastasis, indicating the metastatic capacity of the CD26+ cells [43]. This evidence concerns the gene DPP4 and malignant colon neoplasm.